🏥NIH Grant Review Meetings for Small Businesses - November 2025
The Department of Health and Human Services announces upcoming closed meetings of the Center for Scientific Review. These meetings will focus on the evaluation of grant applications related to health services and innovations, providing vital opportunities for small businesses in the health technology sector.
Learn More⚕️FDA Guidance on In Vitro Diagnostic Tests During Emergencies
The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance entitled "Consideration of Enforcement Policies for In Vitro Diagnostic Tests During a Section 564 Declared Emergency." This guidance describes the factors FDA intends to assess in deciding whether to issue an enforcement policy regarding in vitro diagnostic test manufacturers' offering of certain unapproved in vitro diagnostic tests and unapproved uses of approved in vitro diagnostic tests during a declared emergency.
Learn More🏥Notice of Closed Meeting at National Institute on Drug Abuse
The Department of Health and Human Services announces a closed meeting of the Board of Scientific Counselors at the National Institute on Drug Abuse. The meeting's purpose is to review individual intramural programs and personnel performance, ensuring privacy and compliance with federal provisions. The agenda focuses on critical assessments of investigators and program efficacy.
Learn More🧬NIH Center for Scientific Review Grant Evaluation Meetings Announcement
The Department of Health and Human Services announces closed meetings by the Center for Scientific Review to evaluate grant applications. These discussions will focus on various health-related research initiatives, allowing for significant evaluation of funding opportunities vital for advancing scientific understanding and innovation.
Learn More💰NIH Notice of Closed Meetings for Grant Application Review
The Department of Health and Human Services, through the National Institutes of Health, announces closed meetings for the review of grant applications. The meetings will evaluate significant health-related research proposals, focusing on areas like HIV, cardiovascular health, and more, while ensuring confidentiality regarding sensitive information.
Learn More🏥NIH Notice of Closed Meetings for Grant Applications Review
The Department of Health and Human Services announces closed meetings of the National Institutes of Health's Center for Scientific Review to evaluate grant applications. The meetings, held virtually, will discuss proprietary information and personal privacy related to the applications, emphasizing confidentiality and the significance of the review process.
Learn More💰NIH Announces Grant Review Meetings for Small Businesses in Health
The Department of Health and Human Services announces upcoming meetings of the Center for Scientific Review, focusing on the evaluation of grant applications related to various health research initiatives. Special emphasis is placed on small businesses, indicating opportunities for financial assistance in the health sector. The meetings will be held virtually, maintaining confidentiality of discussions and applications.
Learn More🦷Closed Meeting Notice for National Institute of Dental Research
The Department of Health and Human Services announces a closed meeting of the Board of Scientific Counselors for the National Institute of Dental and Craniofacial Research to evaluate individual programs and personnel qualifications. The virtual meeting aims to discuss the competencies of investigators and relevant intramural projects, ensuring a high standard of research in the field.
Learn More💰NIH Announces Closed Meetings for Grant Evaluations in December 2025
The Department of Health and Human Services published a notice regarding closed meetings held by the National Institutes of Health to review and evaluate grant applications. These meetings aim to assess proposals related to significant health and biomedical issues, maintaining confidentiality concerning sensitive information.
Learn More💊FDA Releases Draft Guidance for Malaria Drug Development
The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Malaria: Developing Drugs for Treatment." The purpose of this draft guidance is to assist sponsors in the overall development program for drug and biological products for the treatment of malaria, caused by clinically relevant Plasmodium species.
Learn More